Stockreport

Cytokinetics, Inc. Reports First Quarter 2018 Financial Results

Cytokinetics, Incorporated  (CYTK) 
Last cytokinetics, incorporated earnings: 3/3 04:00 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytokinetics.com/investor-overview
PDF Completed Enrollment in Phase 2 Study of Reldesemtiv in Patients with SMA;Data Expected in Q2 2018 Preparing to Initiate Second Phase 3 Clinical Trial of Omecamtiv Meca [Read more]